Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice. [electronic resource]
- British journal of pharmacology May 2016
- 1517-28 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5381
10.1111/bph.13453 doi
Animals Apolipoproteins E--deficiency Atherosclerosis--drug therapy Digoxin--blood Dose-Response Relationship, Drug Inflammation--drug therapy Interleukin-17--immunology Mice Mice, Inbred C57BL Mice, Knockout Nuclear Receptor Subfamily 1, Group F, Member 3--antagonists & inhibitors